Erythropoietin (EPO) ameliorates obesity and glucose homeostasis by promoting thermogenesis and endocrine function of classical brown adipose tissue (BAT) in diet-induced obese mice

Erythropoietin (EPO), clinically used as a hematopoietic drug, has received much attention due to its nonhematopoietic effects. EPO reportedly has beneficial effects on obesity and diabetes mellitus. We investigated whether interscapular brown adipose tissue (iBAT: main part of classical BAT) could...

Descripción completa

Detalles Bibliográficos
Autores principales: Kodo, Kazuki, Sugimoto, Satoru, Nakajima, Hisakazu, Mori, Jun, Itoh, Ikuyo, Fukuhara, Shota, Shigehara, Keiichi, Nishikawa, Taichiro, Kosaka, Kitaro, Hosoi, Hajime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348037/
https://www.ncbi.nlm.nih.gov/pubmed/28288167
http://dx.doi.org/10.1371/journal.pone.0173661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348037/
https://www.ncbi.nlm.nih.gov/pubmed/28288167
http://dx.doi.org/10.1371/journal.pone.0173661

Ejemplares similares